Lidocaine Hydrochloride Monohydrate Чайкафарма

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Monohydrate Чайкафарма, is a local anesthetic presented as a sterile injectable solution for intramuscular, intravenous, or subcutaneous use. It provides rapid onset of numbness for minor surgical procedures, pain management, and can be used intravenously for ventricular arrhythmias in appropriate clinical settings.

GNH USA supplies Lidocaine Hydrochloride Monohydrate Чайкафарма as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is a local anesthetic that blocks nerve conduction in targeted tissues. - Minor surgical procedures: produces rapid, reversible loss of sensation to facilitate surgery without general anesthesia. - Pain management: provides localized analgesia for acute pain, burns, or postoperative discomfort. - Ventricular arrhythmias (IV administration): stabilises cardiac rhythm by reducing ectopic activity during emergency treatment.

Lidocaine Hydrochloride may cause a range of adverse reactions, most of which are related to the route of administration and plasma concentration.

Common Side Effects: - Injection site pain or burning sensation. - Tingling or numbness beyond the target area. - Nausea or mild vomiting. - Dizziness or light‑headedness. - Metallic taste in the mouth. - Transient hypotension.

Serious or Rare Side Effects: - Cardiac arrhythmias or conduction block. - Seizures, especially with high plasma levels. - Methemoglobinemia. - Severe allergic reactions (anaphylaxis, angioedema). - Respiratory depression. - Cardiovascular collapse.

When using Lidocaine Hydrochloride, clinicians should consider several safety measures. - Cardiac assessment: evaluate history of heart block or conduction disorders before IV use. - Hepatic function: reduce dose or monitor closely in patients with severe liver impairment. - Allergy check: avoid in individuals with known lidocaine or amide‑type anesthetic hypersensitivity. - Infusion monitoring: observe for signs of toxicity during prolonged intravenous administration. - Elderly patients: start with lower doses and titrate cautiously. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Lidocaine Hydrochloride can alter or be altered by other medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) – may increase lidocaine plasma levels and toxicity. - Amiodarone – synergistic cardiac depressant effects. - Cimetidine – reduces hepatic metabolism, raising lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers and calcium channel blockers – additive effects on heart rate and contractility. - General anesthetics (e.g., propofol, volatile agents) – may enhance central nervous system depression. - CYP3A4 inhibitors (e.g., erythromycin) – modest increase in lidocaine exposure.